Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FST-100 in acute adenoviral conjunctivitis
NCT01470664Phase 2Completed
- Sponsor
- Takeda
- Start
- Dec 2012
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of dexamethasone, povidone-iodine 2% ophthalmic solution in acute adenoviral conjunctivitis, sponsored by Takeda. Started Dec 2012; status: completed.
02
Drugs
dexamethasonepovidone-iodine 2% ophthalmic solution
03
Conditions
acute adenoviral conjunctivitis
Beyond the preview
Go deeper on NCT01470664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470664.